PathoGenetix(TM), Inc. is a commercial-stage developer of an automated system for rapid bacterial identification from complex samples. PathoGenetix is a venture-backed company that has received more than $50 million in technology development funding from the Department of Homeland Security. The core Genome Sequence Scanning(TM) (GSS(TM)) technology analyzes DNA from an enriched biological sample--without the need for a cultured isolate--and provides results in five hours. GSS has broad applicability in food safety, industrial microbiology, and clinical diagnostics and research. The GSS technology will be available in the RESOLUTION(TM) Microbial Genotyping System in 2014 for use in food safety testing and foodborne illness outbreak investigations.